These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2732445

  • 1. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [Abstract] [Full Text] [Related]

  • 2. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C, Finucci G, Zuin R, Bazzerla G, Bolognesi M, Sacerdoti D, Gatta A.
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [Abstract] [Full Text] [Related]

  • 3. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 4. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [Abstract] [Full Text] [Related]

  • 5. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Sep; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J.
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.
    Hepatology; 1990 Feb 15; 11(2):230-8. PubMed ID: 2307401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of sublingual isosorbide dinitrate in portal hypertension.
    Bhatia SJ, Deshmukh H, Abraham P, Shah AV, Vontivillu JA, Jagasia DH, Kothari RH.
    Indian J Gastroenterol; 1990 Apr 15; 9(2):113-5. PubMed ID: 2323797
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.
    J Gastroenterol; 1994 Aug 15; 29(4):460-8. PubMed ID: 7951857
    [Abstract] [Full Text] [Related]

  • 15. Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.
    Freeman JG, Barton JR, Record CO.
    Br Med J (Clin Res Ed); 1985 Aug 31; 291(6495):561-2. PubMed ID: 3929873
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep 31; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.
    Gastroenterol Hepatol; 2000 Sep 31; 23(6):275-81. PubMed ID: 15324622
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
    Silva G, Fluxá F, Ruiz M, Bresky G, Barrientos C, Backhouse C, Palma M, Iturriaga H.
    Rev Med Chil; 1993 Aug 31; 121(8):889-96. PubMed ID: 8296096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.